Infectious Diseases Consult Service
Juan C Gea-Banacloche, M.D.
Senior Infectious Diseases Consultant, Division of Clinical Research, NIAID
Attending, General and Transplant Infectious Diseases Consultation Service, NIH Clinical Center
Major Areas of Research
- Immune reconstitution after allogeneic Hematopoietic Stem Cell Transplantation
- Infections in transplant recipients
Program Description
Provide direct clinical care to patients requiring management of infectious diseases in the Clinical Center as an attending on the general ID and transplant ID consult service.
Work closely with the transplant ID service to strengthen teaching and develop the educational experience of ID fellows rotating on the service and the transplant ID fellow.
Work closely with the transplant ID service to develop the new NIH transplant ID fellowship.
Provide infectious disease expertise in the management of pre- and post-transplant clinical care.
Provides ID consultation/support to DCR special projects as requested.
Biography
Education
M.D., 1986, Universidad Autónoma de Madrid, Madrid, Spain
Internal Medicine, 1992, Clínica Puerta de Hierro, Madrid, Spain
Dr. Gea-Banacloche completed his medical studies and internal medicine training in Madrid, Spain. He came to NIH with a fellowship in allergy and immunology, followed by a fellowship in infectious diseases at NIAID. His focus has been on immune reconstitution and opportunistic infections, initially as a fellow focusing on AIDS and later as an Infectious Diseases physician focusing on infections in recipients of hematopoietic stem cell transplant, solid organ transplant, and cellular therapy.
After many years as Chief of the Infectious Disease Consult Service at the NIH Clinical Center, he worked as a consultant in infectious diseases at the Mayo Clinic Hospital in Phoenix, Arizona. He returned to NIH in 2021 to join the NIAID Division of Clinical Research as a senior consultant in infectious diseases. He attends on the Infectious Diseases Consult Service at the NIH Clinical Center (both general and transplant) and is part of the NIAID Infectious Diseases Fellowship Program faculty.
Selected Publications
Gea-Banacloche JC. Infectious complications of chimeric antigen receptor (CAR) T-cell therapies. Semin Hematol. 2023 Jan;60(1):52-58.
Gea-Banacloche J, Komanduri KV, Carpenter P, Paczesny S, Sarantopoulos S, Young JA, El Kassar N, Le RQ, Schultz KR, Griffith LM, Savani BN, Wingard JR. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report. Biol Blood Marrow Transplant. 2017 Jun;23(6):870-881.
Gea-Banacloche JC. Rituximab-associated infections. Semin Hematol. 2010 Apr;47(2):187-98.
Gea-Banacloche J, Masur H, Arns da Cunha C, Chiller T, Kirchhoff LV, Shaw P, Tomblyn M, Cordonnier C; Center for International Blood and Marrow Transplant Research; National Marrow Donor Program; European Blood and Marrow Transplant Group; American Society of Blood and Marrow Transplantation; Canadian Blood and Marrow Transplant Group; Infectious Disease Society of America; Society for Healthcare Epidemiology of America; Association of Medical Microbiology and Infectious Diseases Canada; Centers for Disease Control and Prevention. Regionally limited or rare infections: prevention after hematopoietic cell transplantation. Bone Marrow Transplant. 2009 Oct;44(8):489-94.
Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM; Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004 Mar;32(3):858-73.
Gea-Banacloche JC, Clifford Lane H. Immune reconstitution in HIV infection. AIDS. 1999;13 Suppl A:S25-38.